ciprofloxacin has been researched along with Bacterial Overgrowth Syndrome in 1 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ciprofloxacin was the most common antibiotic used for treatment, and 70% of patients reported a good response to the initial course of treatment." | 1.36 | Bacterial overgrowth syndrome in myotonic muscular dystrophy is potentially treatable. ( Armstrong, D; James, C; Matteliano, A; Pearce, E; Tarnopolsky, MA, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tarnopolsky, MA | 1 |
| Pearce, E | 1 |
| Matteliano, A | 1 |
| James, C | 1 |
| Armstrong, D | 1 |
1 other study available for ciprofloxacin and Bacterial Overgrowth Syndrome
| Article | Year |
|---|---|
Bacterial overgrowth syndrome in myotonic muscular dystrophy is potentially treatable.
Topics: Adult; Anti-Infective Agents; Blind Loop Syndrome; Breath Tests; Ciprofloxacin; Female; Humans; Inte | 2010 |